Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 7065 - 7072 of 12016 results
Legislation Limiting an Employer's Ability to Inquire About and Consider Applicants' Prior Salary History Gains Momentum
April 21, 2017| Blog| Viewpoint
Kimpton Data Breach Decision Highlights Lingering Confusion on Standing Issues
April 21, 2017| Blog| Viewpoint
Rules and Practice Tips Regarding Official Notice at the U.S. Patent and Trademark Office
April 21, 2017| Blog| Viewpoint
State of Advanced Energy: Advanced Energy is Strong, but Policy Matters (Part 5 of 5)
April 20, 2017| Blog| Viewpoint
Mintz Matrix Updated with New State Data Breach Notification Laws
April 20, 2017| Blog| Viewpoint
Massachusetts Budget Process Continues with Impact on Health Care
April 20, 2017| Blog| Viewpoint
Textualism Takes Center Stage In CalPERS V. ANZ Securities
April 20, 2017| News
SEC’s Investor Advisory Committee Airs Concerns Over Multi-Tiered Offerings Following Snap’s IPO
April 19, 2017| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|